U.S. Patent Office: Artificial Intelligence Cannot be a Legal Inventor

May 1st, 2020

Via: The Verge:

The US Patent and Trademark Office (USPTO) has ruled that artificial intelligence systems cannot be credited as an inventor in a patent, the agency announced earlier this week. The decision came in response to two patents — one for a food container and the other for a flashing light — that were created by an AI system called DABUS.

Among the USPTO’s arguments is the fact that US patent law repeatedly refers to inventors using humanlike terms such as “whoever” and pronouns like “himself” and “herself.” The group behind the applications had argued that the law’s references to an inventor as an “individual” could be applied to a machine, but the USPTO said this interpretation was too broad. “Under current law, only natural persons may be named as an inventor in a patent application,” the agency concluded.


Guess Who’s Growing Your Meat?

April 30th, 2020

Via: Corbett Report:


Funeral Directors in COVID-19 Epicenter Doubt Legitimacy of Deaths Attributed to Pandemic, Fear Numbers are ‘Padded’

April 30th, 2020

Via: Project Veritas:


Starlink 6, Two Days After Launch

April 30th, 2020

Via: Sebastian Voltmer:

Shooting the satellite batches: Starlink 6 two days after launch! from Sebastian Voltmer on Vimeo.


Contact Tracing With The Clintons [???]

April 30th, 2020

You’ll love this one.

Via: Please Stop the Ride:


Trump’s ‘Operation Warp Speed’ Aims to Rush Coronavirus Vaccine

April 29th, 2020

Mmm hmm.

Trump supporters: Roll up your sleeves!

In other news: Bill Gates: “The Final Solution, Which Is a Year to Two Years Off, Is the Vaccine.”

Via: Bloomberg:

The Trump administration is organizing a Manhattan Project-style effort to drastically cut the time needed to develop a coronavirus vaccine, with a goal of making enough doses for most Americans by year’s end.

Called “Operation Warp Speed,” the program will pull together private pharmaceutical companies, government agencies and the military to try to cut the development time for a vaccine by as much as eight months, according to two people familiar with the matter.

As part of the arrangement, taxpayers will shoulder much of the financial risk that vaccine candidates may fail, instead of drug companies.

The project’s goal is to have 300 million doses of vaccine available by January, according to one administration official. There is no precedent for such rapid development of a vaccine.


Cities Face 100 Million ‘New Poor’ in Post-Pandemic World

April 29th, 2020

Via: Reuters:

About 100 million people living in cities worldwide will likely fall into poverty due to the coronavirus pandemic, urban experts said on Wednesday, calling for mapping tools to identify vulnerable communities and investment focusing on slum areas.

Densely populated cities are poised at the frontline of the contagious outbreak, hard hit where people live in poverty with little or no running water, sewage systems or health care access, said experts at the World Bank, the World Resources Institute (WRI) and other urban-study groups.

“Within cities we need to focus on those who need help the most, the poor and the vulnerable have been very seriously affected,” said Sameh Wahba, global director for the World Bank’s urban, disaster risk management, resilience and land global practice.

“Our estimate is that there will be possibly upward of a 100 million so-called ‘new poor’ on account of loses of jobs and livelihoods and income,” Wahba told a webinar with members of the media.

He warned that cities will see a drop of between 15% to 25% in tax revenues next year, making it difficult for authorities to invest in improving slum areas.


Dr. Fauci Backed Controversial Wuhan Lab with Millions of U.S. Dollars for Risky Coronavirus “Gain of Function” Research

April 29th, 2020

Via: Newsweek:

But just last year, the National Institute for Allergy and Infectious Diseases, the organization led by Dr. Fauci, funded scientists at the Wuhan Institute of Virology and other institutions for work on gain-of-function research on bat coronaviruses.

In 2019, with the backing of NIAID, the National Institutes of Health committed $3.7 million over six years for research that included some gain-of-function work. The program followed another $3.7 million, 5-year project for collecting and studying bat coronaviruses, which ended in 2019, bringing the total to $7.4 million.

Many scientists have criticized gain of function research, which involves manipulating viruses in the lab to explore their potential for infecting humans, because it creates a risk of starting a pandemic from accidental release.

The NIH research consisted of two parts. The first part began in 2014 and involved surveillance of bat coronaviruses, and had a budget of $3.7 million. The program funded Shi Zheng-Li, a virologist at the Wuhan lab, and other researchers to investigate and catalogue bat coronaviruses in the wild. This part of the project was completed in 2019.

A second phase of the project, beginning that year, included additional surveillance work but also gain-of-function research for the purpose of understanding how bat coronaviruses could mutate to attack humans. The project was run by EcoHealth Alliance, a non-profit research group, under the direction of President Peter Daszak, an expert on disease ecology. NIH canceled the project just this past Friday, April 24th, Politico reported. Daszak did not immediately respond to Newsweek requests for comment.

The project proposal states: “We will use S protein sequence data, infectious clone technology, in vitro and in vivo infection experiments and analysis of receptor binding to test the hypothesis that % divergence thresholds in S protein sequences predict spillover potential.”

In layman’s terms, “spillover potential” refers to the ability of a virus to jump from animals to humans, which requires that the virus be able to receptors in the cells of humans. SARS-CoV-2, for instance, is adept at binding to the ACE2 receptor in human lungs and other organs.

According to Richard Ebright, an infectious disease expert at Rutgers University, the project description refers to experiments that would enhance the ability of bat coronavirus to infect human cells and laboratory animals using techniques of genetic engineering. In the wake of the pandemic, that is a noteworthy detail.

A decade ago, during a controversy over gain-of-function research on bird-flu viruses, Dr. Fauci played an important role in promoting the work. He argued that the research was worth the risk it entailed because it enables scientists to make preparations, such as investigating possible anti-viral medications, that could be useful if and when a pandemic occurred.

The work in question was a type of gain-of-function research that involved taking wild viruses and passing them through live animals until they mutate into a form that could pose a pandemic threat. Scientists used it to take a virus that was poorly transmitted among humans and make it into one that was highly transmissible—a hallmark of a pandemic virus. This work was done by infecting a series of ferrets, allowing the virus to mutate until a ferret that hadn’t been deliberately infected contracted the disease.

The work entailed risks that worried even seasoned researchers. More than 200 scientists called for the work to be halted. The problem, they said, is that it increased the likelihood that a pandemic would occur through a laboratory accident.


GOP Senator Asks DOJ to Open a Criminal Investigation Into Amazon

April 29th, 2020

Via: CNBC:

Sen. Josh Hawley, R-Mo., is asking the Department of Justice to open a criminal investigation into Amazon, citing reports that he says suggest the company has used “predatory and exclusionary data practices to build and maintain a monopoly.”

Hawley’s request follows Friday’s Wall Street Journal report that said Amazon employees had used data from third-party sellers to rival them with private label products under Amazon’s own brands.

Amazon has previously testified to the House Antitrust Subcommittee that it only uses aggregated data from multiple third-party sellers to inform its product strategy, and did not look at sales data for individual products. But the Journal, after reviewing documents and interviewing more than 20 former employees, found that individual seller data could be easily deduced for some categories, making the distinction irrelevant in practice.


Bill Gates: “The Final Solution, Which Is a Year to Two Years Off, Is the Vaccine.”

April 29th, 2020

“Just to head off the conspiracy theorists, maybe we shouldn’t call the vaccine the final solution. Maybe just the best solution.”

You couldn’t make it up if you tried. Maybe I need to start watching TV. This is incredible.

Via: The Late Show with Stephen Colbert:


« Previous PageNext Page »